2030 年までのヨーロッパのバイオプロダクション市場予測 - 地域別分析 - 製品別 (生物製剤およびバイオシミラー、ワクチン、細胞および遺伝子治療、核酸治療、その他)、用途別 (関節リウマチ、血液疾患、がん、糖尿病、心血管疾患、その他)、装置別 (上流装置、下流装置、バイオリアクター、消耗品および付属品)、およびエンドユーザー別 (バイオ医薬品会社、契約製造組織、その他)
慢性疾患の有病率の増加がヨーロッパのバイオプロダクション市場を牽引
心血管疾患（CVD）、神経疾患、自己免疫疾患、および癌は、世界中でかなりの割合で死亡および障害を引き起こしている慢性疾患の一部です。世界保健機関（WHO）によると、CVDは世界の死因の第1位であり、毎年推定1,790万人の命を奪っています。癌はまた、世界中で死亡の主な原因の1つであり、膨大な人口に影響を与えているため、社会に大きな経済的負担をかけています。WHOによると、2020年には世界中で約1,000万人が癌で亡くなりました。しかし、この疾患の効果的な治療法の開発に関する研究が進むことで、市場の成長にプラスの影響を与えています。遺伝子治療と細胞治療は、がん治療の状況を一変させています。たとえば、ノバルティスのキムリアは、びまん性大細胞型B細胞リンパ腫の治療に使用されています。
さらに、患者、専門医、プライマリケアの臨床医、その他の医療専門家がバイオシミラーを有効かつ安全な薬剤として認識していることで、バイオシミラーの需要が高まっています。さらに、バイオシミラーは、何百万人もの患者の生活を改善すると同時に、医療制度の年間コストを数十億ドル節約しています。バイオシミラーは、クローン病、乾癬、過敏性腸症候群、大腸炎などの慢性皮膚疾患や腸疾患、糖尿病、自己免疫疾患、がん、腎臓疾患、関節炎など、多くの疾患の治療に効果的で費用対効果の高い選択肢です。
慢性疾患の有病率が急速に増加しているため、生命を脅かす疾患の治療におけるバイオプロダクションの需要は過去5年間で急速に進歩し、バイオプロダクション市場を牽引しています。
ヨーロッパのバイオプロダクション市場の概要
ヨーロッパのバイオプロダクション市場は、ドイツ、英国、フランス、イタリア、スペイン、その他のヨーロッパに分かれています。ヨーロッパは世界のバイオプロダクション市場で重要な位置を占めており、2022年から2030年にかけて顕著なCAGRを記録すると予想されています。慢性疾患の有病率の上昇により、製品の発売と承認の数が増加し、技術の進歩と投資も進み、この地域の市場成長に貢献しています。
バイオシミラーは競争をもたらし、生物学的製剤の価格を手頃なものにし、最終的には患者のケアと医療業界を支援するための節約と付加価値サービスを提供します。医療従事者は、より多くの患者を低コストで高品質の生物学的製剤で治療することができます。コスト削減の大きな可能性があることから、ドイツ保健省はバイオシミラーの採用を増やすための新しい法律を導入しました。いくつかの欧州連合（EU）諸国では薬剤師によるバイオシミラーの代替が許可されているため、これは特にドイツにとって実践上の大きな変化を意味します。さらに、PHI整形外科理学療法センター、ドイツ国際クリニック（ドイツ、フランクフルト）、CBCヘルスミュンヘン（ドイツ）などの医療提供者は、糖尿病性網膜症、視神経炎、関節リウマチなどのさまざまな慢性疾患に対する幹細胞療法を提供しています。これにより、今後数年間で細胞療法の採用が増加すると予想されます。また、国際的なプレーヤー間のパートナーシップの増加も市場の成長を後押ししています。たとえば、2020年11月、日立化成アドバンストセラピューティクスソリューションズLLCとapceth Biopharma GmbHは、ブルーバードバイオとの関係を拡大し、複数の治療法の臨床および商業供給に関する長期開発および製造サービス契約を締結しました。これには、輸血依存性βサラセミア（TDT）に対する1回限りの遺伝子治療であるZYNTEGLOのヨーロッパでの商用医薬品製造能力の拡大が含まれます。したがって、ドイツでバイオシミラーを採用するための政府の取り組みが拡大するにつれて、市場は繁栄すると予想されます。
ヨーロッパのバイオプロダクション市場の収益と2030年までの予測（百万米ドル）
ヨーロッパのバイオプロダクション市場のセグメンテーション
ヨーロッパのバイオプロダクション市場は、製品、アプリケーション、機器、エンドユーザー、および国に分類されています。
製品に基づいて、ヨーロッパのバイオプロダクション市場は、生物製剤とバイオシミラー、ワクチン、細胞および遺伝子治療、核酸治療、その他に分類されています。生物製剤とバイオシミラーセグメントは、2022年にヨーロッパのバイオプロダクション市場で最大のシェアを占めました。
アプリケーションの観点から、ヨーロッパのバイオプロダクション市場は、関節リウマチ、血液疾患、がん、糖尿病、心血管疾患、その他に分類されています。がんセグメントは、2022年にヨーロッパのバイオプロダクション市場で最大のシェアを占めました。
機器別に、ヨーロッパのバイオプロダクション市場は、上流機器、下流機器、バイオリアクター、消耗品とアクセサリに分かれています。消耗品および付属品セグメントは、2022年にヨーロッパのバイオプロダクション市場で最大のシェアを占めました。
エンドユーザーの観点から見ると、ヨーロッパのバイオプロダクション市場は、バイオ医薬品会社、契約製造組織、その他に分類されます。バイオ医薬品会社セグメントは、2022年にヨーロッパのバイオプロダクション市場で最大のシェアを占めました。
国別に見ると、ヨーロッパのバイオプロダクション市場は、ドイツ、イギリス、フランス、イタリア、スペイン、その他のヨーロッパに分かれています。2022年には、ドイツがヨーロッパのバイオプロダクション市場シェアを独占しました。
Lonza Group AG、bbi-biotech GmbH、Danaher Corp、Sartorius AG、FUJIFILM Irvine Scientific Inc、Thermo Fisher Scientific Inc、Merck KGaA、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc.は、ヨーロッパのバイオプロダクション市場で事業を展開している大手企業の一部です。
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - Europe Market Analysis
5.1 Europe Bioproduction Market Revenue (US$ Mn), 2020 - 2030
6. Europe Bioproduction Market - Revenue and Forecast to 2030 - by Product
6.1 Overview
6.2 Europe Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Bioproduction Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 Europe Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Bioproduction Market - Revenue and Forecast to 2030 - by Equipment
8.1 Overview
8.2 Europe Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Europe: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Bioproduction Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Europe Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis
10.1 Europe: Bioproduction Market
10.1.1 Europe: Bioproduction Market, by Country, 2022 & 2030 (%)
10.1.1.1 Germany: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Germany: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.2 Germany: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.1.3 Germany: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 Germany: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.1.4.1 Germany: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.1.5 Germany: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 UK: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 UK: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 UK: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.4 UK: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.5 UK: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.2.5.1 UK: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.6 UK: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 France: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 France: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 France: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.3.4 France: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.5 France: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.3.5.1 France: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.3.6 France: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Italy: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Italy: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.4 Italy: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.5 Italy: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.4.5.1 Italy: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.6 Italy: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.5 Spain: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 Spain: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.5.4 Spain: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.5.5 Spain: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.5.5.1 Spain: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.5.6 Spain: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.6 Rest of Europe: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Europe: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of Europe: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.6.5 Rest of Europe: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.6.5.1 Rest of Europe: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.6.6 Rest of Europe: Bioproduction Market, by End User, 2020-2030 (US$ Million)
11. Bioproduction Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 . Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 bbi-biotech GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danaher Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sartorius AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 FUJIFILM Irvine Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bio-Rad Laboratories Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
?
List of Tables
Table 1. Europe Bioproduction Market Segmentation
Table 2. Europe Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. Germany Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Germany Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. Germany Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. Germany Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. UK Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. UK Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. UK Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. UK Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. UK Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. France Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. France Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. France Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 16. France Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. France Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Italy Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 19. Italy Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 20. Italy Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 21. Italy Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 22. Italy Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. Spain Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 24. Spain Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. Spain Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 26. Spain Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 27. Spain Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 28. Rest of Europe Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 29. Rest of Europe Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 30. Rest of Europe Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Europe Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Europe Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 33. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 34. Recent Organic Growth Strategies in the Bioproduction Market
Table 35. Glossary of Terms, Bioproduction Market
?
List of Figures
Figure 1. Europe Bioproduction Market Segmentation, By Country
Figure 2. Europe Bioproduction Market: Key Industry Dynamics
Figure 3. Europe Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. Europe Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Europe Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Europe Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Europe Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Europe: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. Europe: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. Germany: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. UK: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. France: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Italy: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. Spain: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Rest of Europe: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Growth Strategies in the Bioproduction Market
1. bbi-biotech GmbH
2. Bio-Rad Laboratories Inc
3. Danaher Corp
4. F. Hoffmann-La Roche Ltd
5. FUJIFILM Irvine Scientific Inc
6. Lonza Group AG
7. Merck KGaA
8. Sartorius AG
9. Thermo Fisher Scientific Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.